Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 142

Sort by

Sort Order Select

Journal Articles

Tracking of Leukemia and Immune Single Cell Phenotypes during Ipilimumab-Based Treatment By Long-Read Sequencing

Livius Penter, Mehdi Borji, Adi Nagler, Haoxiang Lyu, Wesley S Lu, Nicoletta Cieri, Alexandria Maurer, Giacomo Oliveira, Aziz M. Al'Khafaji, Kiran Garimella, Shuqiang Li, Donna S. Neuberg, Jerome Ritz, Robert J. Soiffer, Jacqueline S. Garcia, Kenneth J. Livak, Catherine J Wu

Blood (2023) 142 (Supplement 1): 1596.

https://doi.org/10.1182/blood-2023-180016

Published: 2023

Journal Articles

Integrative Single-Cell Tracking of Clonal Evolution, Leukemia Phenotypes and Donor Engraftment Following Allogeneic Stem Cell Transplant Using Mitochondrial DNA Mutations

Livius Penter, Nicoletta Cieri, Katie Maurer, Haoxiang Lyu, Wesley S Lu, Giacomo Oliveira, Satyen H Gohil, Caleb Lareau, Leif S Ludwig, Shuqiang Li, Jerome Ritz, Jacqueline S. Garcia, Robert J. Soiffer, Kenneth J. Livak, Catherine J Wu

Blood (2023) 142 (Supplement 1): 3580.

https://doi.org/10.1182/blood-2023-180113

Published: 2023

Journal Articles

An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse

Blood (2023) 142 (Supplement 1): 361.

https://doi.org/10.1182/blood-2023-187705

Published: 2023

Journal Articles

Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 652.

https://doi.org/10.1182/blood-2023-187451

Published: 2023

Journal Articles

Baseline Immune State and T Cell Clonal Kinetics Are Associated with Response to CAR-T Therapy in Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 223.

https://doi.org/10.1182/blood-2023-180819

Published: 2023

Journal Articles

ASXL1 Truncating Mutations Drive Leukemic Resistance to T Cell Attack

Blood (2023) 142 (Supplement 1): 364.

https://doi.org/10.1182/blood-2023-189177

Published: 2023

Journal Articles

Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft Versus Leukemia Response with Adoptive Cellular Therapy

Alexandria Maurer, Cameron Y Park, Shouvik Mani, Mehdi Borji, Crystal Shin, Livius Penter, James R Brenner, Jackson Southard, Wesley S Lu, Haoxiang Lyu, Shuqiang Li, Kenneth J. Livak, Jerome Ritz, Robert J. Soiffer, Elham Azizi, Catherine J Wu

Blood (2023) 142 (Supplement 1): 363.

https://doi.org/10.1182/blood-2023-189292

Published: 2023

Journal Articles

Leukemia Blasts Induce NK-like Dysfunction in AML-Specific T Cells

Francesco Mazziotta, Lauren E Martin, Miranda Lahman, Daniel N. Egan, Sinéad Kinsella, Kelly Paulson, Yapeng Su, Valentin Voillet, Livius Penter, Catherine J Wu, Philip Greenberg, Aude G Chapuis

Blood (2023) 142 (Supplement 1): 4849.

https://doi.org/10.1182/blood-2023-189773

Published: 2023

Journal Articles

Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2176.

https://doi.org/10.1182/blood-2023-181863

Published: 2023

Journal Articles

Richter syndrome: novel insights into the biology of transformation

Erin M. Parry, Elisa ten Hacken, Catherine J. Wu

Blood (2023) 142 (1): 11–22.

https://doi.org/10.1182/blood.2022016502

Published: 2023

Journal Articles

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Blood (2023) 141 (15): 1884–1888.

https://doi.org/10.1182/blood.2022017686

Published: 2023

Includes: Supplemental data

Journal Articles

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Blood (2023) 141 (15): 1817–1830.

https://doi.org/10.1182/blood.2022018246

Published: 2023

Includes: Supplemental data

Journal Articles

The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia

Adi Nagler, Catherine J. Wu

Blood (2023) 141 (4): 369–379.

https://doi.org/10.1182/blood.2021014669

Published: 2023

Journal Articles

Genomic profiling for clinical decision making in lymphoid neoplasms

Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M. Horwitz, Ari M. Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano A. Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy B. Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L. King, Young H. Ko, Ann S. LaCasce, Georg Lenz, José I. Martin-Subero, Miguel A. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martinez, Scott J. Rodig, Andreas Rosenwald, Gilles A. Salles, Jesus San-Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier L. Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott

Blood (2022) 140 (21): 2193–2227.

https://doi.org/10.1182/blood.2022015854

Published: 2022

Includes: Supplemental data

Journal Articles

Prevalence of Clonal Hematopoiesis of Indeterminate Potential in Patients with Monoclonal B-Cell Lymphocytosis Compared to Untreated Chronic Lymphocytic Leukemia

Anisha V. Patel, Abirami Vijenthira, Aswin Sekar, Christopher J. Gibson, Stephen P. Martindale, Rayan Fardoun, Svitlana Tyekucheva, Stacey M. Fernandes, Binyamin A. Knisbacher, Cynthia K. Hahn, Gad Getz, Catherine J. Wu, Matthew S. Davids, Jennifer R. Brown

Blood (2022) 140 (Supplement 1): 7038–7040.

https://doi.org/10.1182/blood-2022-162707

Published: 2022

Journal Articles

Immuno-Genetic Changes Underlie Response to Immune Checkpoint Blockade Therapy in Richter's Syndrome Mouse Models

Elisa Ten Hacken, Gabriela Brunsting Hoffmann, Kayla Cruz, Erin Michelle Parry, Elizabeth Witten, Donna S. Neuberg, Gordon J Freeman, Catherine J. Wu

Blood (2022) 140 (Supplement 1): 1538–1539.

https://doi.org/10.1182/blood-2022-160465

Published: 2022

Journal Articles

Evolutionary History of Transformation from Chronic Lymphocytic Leukemia to Richter Syndrome

Blood (2022) 140 (Supplement 1): 1530–1533.

https://doi.org/10.1182/blood-2022-160335

Published: 2022

Journal Articles

Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDS

Blood (2022) 140 (Supplement 1): 10198–10199.

https://doi.org/10.1182/blood-2022-157339

Published: 2022

Journal Articles

ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome

Blood (2022) 140 (Supplement 1): 1807–1808.

https://doi.org/10.1182/blood-2022-162550

Published: 2022

Journal Articles

Characteristics of Rare Germline ATM Variants in Chronic Lymphocytic Leukemia (CLL)

Kiyomi Mashima, Benjamin L. Lampson, Aditi Gupta, Nicholas Moore, Anna Petrackova, Samantha J. Shupe, Stacey M. Fernandes, Amaro Taylor-Weiner, Riaz Gillani, Hoyin Chu, Seunghun Han, Sabrina Camp, Eric Kofman, Gad Getz, Catherine J. Wu, Eliezer Van Allen, Saud H AlDubayan, Jennifer R. Brown

Blood (2022) 140 (Supplement 1): 9853–9854.

https://doi.org/10.1182/blood-2022-167009

Published: 2022

NARROW

Tracking of Leukemia and Immune Single Cell Phenotypes during Ipilimumab-Based Treatment By Long-Read Sequencing

Integrative Single-Cell Tracking of Clonal Evolution, Leukemia Phenotypes and Donor Engraftment Following Allogeneic Stem Cell Transplant Using Mitochondrial DNA Mutations

An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse

Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation

Baseline Immune State and T Cell Clonal Kinetics Are Associated with Response to CAR-T Therapy in Large B-Cell Lymphoma

ASXL1 Truncating Mutations Drive Leukemic Resistance to T Cell Attack

Coordinated Immune Cell Networks in the Bone Marrow Microenvironment Define the Graft Versus Leukemia Response with Adoptive Cellular Therapy

Leukemia Blasts Induce NK-like Dysfunction in AML-Specific T Cells

Post-Transplant T Cell Clonotype Diversity Is Associated with Survival in Patients with TP53-Mutated Acute Myeloid Leukemia

Richter syndrome: novel insights into the biology of transformation

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia

Genomic profiling for clinical decision making in lymphoid neoplasms

Prevalence of Clonal Hematopoiesis of Indeterminate Potential in Patients with Monoclonal B-Cell Lymphocytosis Compared to Untreated Chronic Lymphocytic Leukemia

Immuno-Genetic Changes Underlie Response to Immune Checkpoint Blockade Therapy in Richter's Syndrome Mouse Models

Evolutionary History of Transformation from Chronic Lymphocytic Leukemia to Richter Syndrome

Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDS

ZNF683 (Hobit) Marks a CD8+ T Cell Population Associated with Anti-Tumor Immunity Following Anti-PD-1 Therapy for Richter Syndrome

Characteristics of Rare Germline ATM Variants in Chronic Lymphocytic Leukemia (CLL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only